Literature DB >> 12927662

High resolution CT in cystic fibrosis--the contribution of expiratory scans.

Ludger Dorlöchter1, Harald Nes, Gjermund Fluge, Karen Rosendahl.   

Abstract

INTRODUCTION: The use of high-resolution computed tomography (HRCT) is well accepted as an accurate method for evaluation of lung parenchyma in cystic fibrosis (CF). Several scoring methods exist and, in common, all are based on HRCT findings during inspiration alone.
OBJECTIVE: To examine whether expiratory HRCT scans could add information about the degree of mosaic perfusion in patients with CF. METHODS AND PATIENTS: Pulmonary HRCT was performed in 17 CF patients (median age of 12 years) with 1-mm thin sections and 10-mm intervals during inspiration, followed by 1-mm thin sections with 20-mm intervals during expiration. HRCT was scored by using a modified Bhalla method.
RESULTS: The mean HRCT score was 8.2. Out of 17 patients, 11 (65%) demonstrated a pathological mosaic perfusion in expiration, while only three patients showed mosaic perfusion in inspiration. The degree of expiratory mosaic perfusion was graded as severe in nine patients and moderate in two patients. There was a significant correlation between our modified HRCT score and lung function, as measured by forced expiratory volume in 1 s (FEV1% predicted, P<0.01).
CONCLUSION: Mosaic perfusion in expiration was a common pathological HRCT finding in our study group. The clinical significance of this finding needs further evaluation.

Entities:  

Mesh:

Year:  2003        PMID: 12927662     DOI: 10.1016/s0720-048x(02)00097-9

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Dose reduction for CT in children with cystic fibrosis: is it feasible to reduce the number of images per scan?

Authors:  Pim A de Jong; Yasutaka Nakano; Maarten H Lequin; Harm A W M Tiddens
Journal:  Pediatr Radiol       Date:  2005-10-25

2.  Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis.

Authors:  P A de Jong; A Lindblad; L Rubin; W C J Hop; J C de Jongste; M Brink; H A W M Tiddens
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

3.  New severity assessment in cystic fibrosis: signal intensity and lung volume compared to LCI and FEV1: preliminary results.

Authors:  Sabrina Fleischer; Mareen Sarah Kraus; Sergios Gatidis; Winfried Baden; Andreas Hector; Dominik Hartl; Ilias Tsiflikas; Juergen Frank Schaefer
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

4.  Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores.

Authors:  Guillaume Chassagnon; Evangelia I Zacharaki; Sébastien Bommart; Pierre-Régis Burgel; Raphael Chiron; Séverine Dangeard; Nikos Paragios; Clémence Martin; Marie-Pierre Revel
Journal:  Radiol Cardiothorac Imaging       Date:  2020-12-17

5.  An automated computed tomography score for the cystic fibrosis lung.

Authors:  Guillaume Chassagnon; Clémence Martin; Pierre-Régis Burgel; Dominique Hubert; Isabelle Fajac; Nikos Paragios; Evangelia I Zacharaki; Paul Legmann; Joel Coste; Marie-Pierre Revel
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

6.  Transfer coefficient of the lung for carbon monoxide and the accessible alveolar volume: clinically useful if used wisely.

Authors:  J Alberto Neder; Mathieu Marillier; Anne-Catherine Bernard; Denis E O'Donnell
Journal:  Breathe (Sheff)       Date:  2019-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.